Avirulent Probiotic Strain of Escherichia coli, Producing the B-Subunit of Cholera Toxin: Obtainment, Stability of Inheritance, and Expression of the Cloned ctxB Gene
https://doi.org/10.21055/0370-1069-2025-4-156-162
Abstract
The aim of the study was to obtain a cholera toxin B-subunit producer based on the avirulent probiotic strain Escherichia coli M-17 and to study its molecular-genetic and immunogenic properties.
Materials and methods. The genetically marked E. coli KS164 thy polA (pIEM3) strain, containing a recombinant plasmid with the cloned ctxB gene encoding the B-subunit of cholera toxin, and the avirulent E. coli M-17 strain, applied for the production of colicontaining probiotics, were used. The strains were analyzed using various methods: molecular genetics, biochemistry, and immunology.
Results and discussion. Through introducing the recombinant cointegrate plasmid pIEM3 (KmRTcR) with the cloned ctxB gene into E. coli M-17 cells via conjugation, KmRTcR transconjugants with high levels of secreted cholera toxin B-subunit production (10 μg/ml) were obtained. One of these transconjugants (KM147) was used as the producer strain for the protective antigen. It was demonstrated that the constructed E. coli strain KM147(pIEM3) KmRTcR stably inherits the cloned ctxB gene contained in the recombinant plasmid, is capable of producing antitoxic antibodies in immunized animals, and safe for the use in model animals. These properties combined make it promising for future use in the development of prophylactic and diagnostic cholera drugs.
About the Authors
G. V. ChekhovskayaRussian Federation
Galina V. Chekhovskaya,
46, Universitetskaya St., Saratov, 410005
I. M. Krepostnova
Russian Federation
46, Universitetskaya St., Saratov, 410005
D. A. Rybal’chenko
Russian Federation
46, Universitetskaya St., Saratov, 410005
E. Yu. Shchelkanova
Russian Federation
46, Universitetskaya St., Saratov, 410005
N. I. Smirnova
Russian Federation
46, Universitetskaya St., Saratov, 410005
References
1. Finkelstein R.A., LoSpalluto J.J. Pathogenesis of experimental cholera. Preparation and isolation of choleragen and chole¬ ragenoid. J. Exp. Med. 1969; 130(1):185–202. DOI: 10.1084/jem.130.1.185.
2. Sears C.L., Kaper J.B. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol. Rev. 1996; 60(1):167–215. DOI: 10.1128/mr.60.1.167-215.1996.
3. Waldor M.K., Mekalanos J.J. Lysogenic conversion by a flamentous phage encoding cholera toxin. Science. 1996; 272(5270):1910–4. DOI: 10.1126/science.272.5270.1910.
4. Matson J.S., Withey J.H., DiRita V.J. Regulatory networks controlling Vibrio cholerae virulence gene expression. Infect. Immun. 2007; 75(12):5542–9. DOI: 10.1128/IAI.01094-07.
5. Gintsburg A.L., Yanishevsky N.V., MotinV.L., Shaginyan I.A., Vertiev Yu.V., Smirnov G.B. [Arrangement and cloning of Vibrio cholerae El Tor RV79 structure genes of enterotoxin]. Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya [Molecular Genetics, Microbiology and Virology]. 1984; (9):12–8.
6. Yanishevsky N.V., Gintsburg A.L., Vertiev Yu.V., Demme Yu.M., Karataev G.I., Smirnov G.B. [Construction of recombinant plasmids encoding the biosynthesis of the beta-subunit of cholera toxin]. Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya [Molecular Genetics, Microbiology and Virology]. 1987; (4):26–32.
7. Il’ina T.S., Smirnov G.B., Smirnova N.I., Livanova L.F. [pI-EM3 recombinant plasmid DNA encoding the synthesis of the chole¬ ra toxin B subunit, the method of its construction, and the bacterial strain Vibrio cholerae, a producer of the cholera toxin B subunit]. SU Patent No. 1505022, publ. 15.10.1991. Bull. No. 38.
8. Peretts L.G. [The Importance of Normal Microflora for the Human Body]. Moscow: “Medgiz”; 1955. 436 p.
9. Belova I.V., Tochilina A.G., Solov’eva I.V., Efimov E.I., Gorlova I.S., Ivanova T.P., Zhirnov V.A. [Genetic analysis of the probiotic strain Escheriсhia coli M-17 and the potentially probiotic strain Escheriсhia coli ВМ]. Mikrobiologiya [Microbiology]. 2019; 88(3):328–35. DOI: 10.1134/S0026365619030030.
10. Smirnova N.I., Krepostnova I.M., Livanova L.F., Zadnova S.P., Eremin S.A., Il’ina T.S. [Avirulent Vibrio cholerae strain – producer of cholera toxin B-subunit: engineering and molecular-genetic analysis]. Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya [Molecular Genetics, Microbiology and Virology]. 2007; (4):7–13.
11. Nair G.B., Faruque S.M., Bhuiyan N.A., Kamruzzaman M., Siddique A.K., Sack D.A. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitali¬ zed patients with acute diarrhea in Bangladesh. J. Clin. Microbiol. 2002; 40(9):3296–9. DOI: 10.1128/JCM.40.9.3296-3299.2002.
12. Hu D., Liu B., Feng L., Ding P., Guo X., Wang M., Cao B., Reeves P.R., Wang L. Origins of the current seventh cholera pande¬mic. Proc. Natl Acad. Sci. USA. 2016; 113(48):E7730-Е7739. DOI: 10.1073/pnas.1608732113.
13. Smirnova N.I., Badanin D.V., Rybal’chenko D.A., Krasnov Ya.M., Kritskii A.A., Lozovskii Ya.V., Fedorov A.V., Kutyrev V.V. [Variability of the genome of El Tor cholera vibrios isolated before the onset and in different periods of the current pandemic]. Molekulyarnaya Genetika, Mikroabiologiya i Virusologiya [Molecular Genetics, Microbiology and Virology]. 2021; 39(2):25– 37. DOI: 10.17116/molgen20213902125.
14. Olsvik O., Wahlberg J., Petterson B., Uhlén M., Popovic T., Wachsmuth I.K., Fields P.I. Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J. Clin. Microbiol. 1993; 31(1):22–5. DOI: 10.1128/jcm.31.1.22-25.1993.
15. Bhaskaran K., Rowley D. Nutritional studies on Vibrio cholerae. J. Gen. Microbiol. 1956; 15(2):417–22. DOI: 10.1099/00221287-15-2-417.
Review
For citations:
Chekhovskaya G.V., Krepostnova I.M., Rybal’chenko D.A., Shchelkanova E.Yu., Smirnova N.I. Avirulent Probiotic Strain of Escherichia coli, Producing the B-Subunit of Cholera Toxin: Obtainment, Stability of Inheritance, and Expression of the Cloned ctxB Gene. Problems of Particularly Dangerous Infections. 2025;(4):156-162. (In Russ.) https://doi.org/10.21055/0370-1069-2025-4-156-162
JATS XML





































